Your session is about to expire
← Back to Search
Connecting Alaska Native People to Quit Smoking (CAN Quit Trial)
N/A
Waitlist Available
Led By Christi A Patten, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Inclusion
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a Facebook-based program designed to help Alaska Native smokers quit by sharing relatable stories and tips. The goal is to provide a culturally relevant way to support smoking cessation in this high-risk group. The CAN Quit program is a Facebook-based intervention developed to promote smoking cessation among Alaska Native people by connecting them with culturally relevant resources and support.
Eligible Conditions
- Tobacco Use
- Smoking
- Tobacco Smoking
- Smoking/Cigarette Smoking
- Smoking Cessation
- Quitting Smoking
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Biochemically Confirmed Abstinence From Smoking
Smoking Cessation Program Completion
Secondary study objectives
Quit Attempts
Self-reported 7-day Point Prevalence Smoking Abstinence
Self-reported Use of Evidence-based Cessation Treatments
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Facebook+Quitline/Treatment ReferralExperimental Treatment1 Intervention
* Participants join a secret/private, culturally relevant Facebook group moderated by an AN tobacco research counselor for 3 months
* Once daily moderator postings for 30 days, repeated each month for 3 months; plus 3-4 daily check-ins/postings to respond to participant generated content and encourage sharing of personal stories/experiences relevant to all stages of the quitting process and treatment engagement
* Description of tobacco treatment services, phone numbers and web links sent via postal mail (printed materials) and email. Treatment options provide free, professional assistance based on U.S. clinical practice guidelines: (1)AK quitline, (2)regional tribal tobacco cessation programs, and (3)smokefree.gov resources (e.g., free texting program and smartphone application, quit guide)
Group II: Quitline/Treatment ReferralActive Control1 Intervention
Description of tobacco treatment services, phone numbers and web links sent via postal mail (printed materials) and email. Treatment options provide free, professional assistance based on U.S. clinical practice guidelines: (1)AK quitline, (2)regional tribal tobacco cessation programs, and (3)smokefree.gov resources (e.g., free texting program and smartphone application, quit guide)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Facebook Group
2019
N/A
~190
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,060,962 Total Patients Enrolled
7 Trials studying Tobacco Use
5,923 Patients Enrolled for Tobacco Use
National Institute on Drug Abuse (NIDA)NIH
2,594 Previous Clinical Trials
3,328,675 Total Patients Enrolled
34 Trials studying Tobacco Use
11,484 Patients Enrolled for Tobacco Use
Christi A Patten, Ph.D.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
70 Total Patients Enrolled